Zhao F - Search Results

1

Loss of FBP1 facilitates aggressive features of hepatocellular carcinoma cells through the Warburg effect.

Yang J, Wang C, Zhao F, Luo X, Qin M, Arunachalam E, Ge Z, Wang N, Deng X, Jin G, Cong W, Qin W. Yang J, et al. Among authors: zhao f. Carcinogenesis. 2017 Feb 1;38(2):134-143. doi: 10.1093/carcin/bgw109. Carcinogenesis. 2017. PMID: 27742690

2

Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence.

Huang Y, Yang X, Zhao F, Shen Q, Wang Z, Lv X, Hu B, Yu B, Fan J, Qin W. Huang Y, et al. Among authors: zhao f. Med Oncol. 2014 Jul;31(7):966. doi: 10.1007/s12032-014-0966-8. Epub 2014 May 31. Med Oncol. 2014. PMID: 24878698

3

The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.

Hu B, Xiong Y, Ni R, Wei L, Jiang D, Wang G, Wu D, Xu T, Zhao F, Zhu M, Wan C. Hu B, et al. Among authors: zhao f. Mol Cell Biochem. 2014 Nov;396(1-2):175-85. doi: 10.1007/s11010-014-2153-9. Epub 2014 Aug 1. Mol Cell Biochem. 2014. PMID: 25081333

4

Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.

Ge T, Shen Q, Wang N, Zhang Y, Ge Z, Chu W, Lv X, Zhao F, Zhao W, Fan J, Qin W. Ge T, et al. Among authors: zhao f, zhao w. Med Oncol. 2015 Mar;32(3):59. doi: 10.1007/s12032-014-0367-z. Epub 2015 Feb 6. Med Oncol. 2015. PMID: 25652109

5

High CHMP4B expression is associated with accelerated cell proliferation and resistance to doxorubicin in hepatocellular carcinoma.

Hu B, Jiang D, Chen Y, Wei L, Zhang S, Zhao F, Ni R, Lu C, Wan C. Hu B, et al. Among authors: zhao f. Tumour Biol. 2015 Apr;36(4):2569-81. doi: 10.1007/s13277-014-2873-1. Epub 2015 Feb 11. Tumour Biol. 2015. PMID: 25874485

6

Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma.

Lv X, Zhao F, Huo X, Tang W, Hu B, Gong X, Yang J, Shen Q, Qin W. Lv X, et al. Among authors: zhao f. Med Oncol. 2016 Jul;33(7):70. doi: 10.1007/s12032-016-0785-1. Epub 2016 Jun 4. Med Oncol. 2016. PMID: 27262566

7

Overexpression of PCBP2 contributes to poor prognosis and enhanced cell growth in human hepatocellular carcinoma.

Zhang X, Hua L, Yan D, Zhao F, Liu J, Zhou H, Liu J, Wu M, Zhang C, Chen Y, Chen B, Hu B. Zhang X, et al. Among authors: zhao f. Oncol Rep. 2016 Dec;36(6):3456-3464. doi: 10.3892/or.2016.5167. Epub 2016 Oct 13. Oncol Rep. 2016. PMID: 27748915

8

Upregulated expression of Nucleostemin/GNL3 is associated with poor prognosis and Sorafenib Resistance in Hepatocellular Carcinoma.

Hua L, Hu B, Yan D, Liu J, Shen Y, Zhao F, Shen C, Chen B, Cui X. Hua L, et al. Among authors: zhao f. Pathol Res Pract. 2017 Jun;213(6):688-697. doi: 10.1016/j.prp.2016.11.014. Epub 2016 Nov 27. Pathol Res Pract. 2017. PMID: 28476378

9

Downregulation of Nedd4L predicts poor prognosis, promotes tumor growth and inhibits MAPK/ERK signal pathway in hepatocellular carcinoma.

Zhao F, Gong X, Liu A, Lv X, Hu B, Zhang H. Zhao F, et al. Biochem Biophys Res Commun. 2018 Jan 1;495(1):1136-1143. doi: 10.1016/j.bbrc.2017.11.139. Epub 2017 Nov 22. Biochem Biophys Res Commun. 2018. PMID: 29175326

10

Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosis.

Zhao F, Liu A, Gong X, Chen H, Wei J, Chen B, Chen S, Yang R, Fan Y, Mao R. Zhao F, et al. Tumori. 2022 Feb;108(1):63-76. doi: 10.1177/03008916211026019. Epub 2021 Jun 24. Tumori. 2022. PMID: 34165025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,473 results

Search Page

Filters